Neola Medical Granted European Patent for Lung Monitoring, Strengthens Protection in Key Markets
Neola Medical has been granted a European patent that strengthens the protection of its core innovation for continuous lung monitoring using gas absorption spectroscopy. The European patent broadens the company’s portfolio of medical patents and complements existing protections in other key markets, including the recently granted Chinese patent from the same patent family. The patent application is pending in the U.S.
“Europe represents one of our main markets alongside the U.S., and the granted patent strengthens our strategic position in this important region. It further reinforces our intellectual property portfolio around our core medical technology for non-invasive lung monitoring and detection of pulmonary complications," says CEO Hanna Sjöström
The granted medical patent is the second validation within the new patent family focused on the protection of advanced methods for detecting pulmonary and aeration complications. The patented innovation combines gas absorption spectroscopy with the measurement of transmitted light through the body to enable continuous, non-invasive monitoring of lung physiology.
About the new patent family
This new patent family “A device for monitoring a pulmonary system of a subject” complements the protection of the company’s first patent family, “Human cavity gas measurement device and method”, a general patent that protects the fundamental concept of measuring gases in body cavities using diode laser spectroscopy.